Literature DB >> 33499806

Efficiency of non-invasive prenatal screening in pregnant women at advanced maternal age.

Hui Zhu1,2, Xiaoxiao Jin2, Yuqing Xu2, Weihua Zhang1, Xiaodan Liu1, Jinglei Jin2, Yeqing Qian2, Minyue Dong3.   

Abstract

BACKGROUND: Non-invasive prenatal screening (NIPS) is widely used as the alternative choice for pregnant women at high-risk of fetal aneuploidy. However, whether NIPS has a good detective efficiency for pregnant women at advanced maternal age (AMA) has not been fully studied especially in Chinese women.
METHODS: Twenty-nine thousand three hundred forty-three pregnant women at AMA with singleton pregnancy who received NIPS and followed-up were recruited. The sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV), receiver operating characteristic (ROC) curves and the Youden Index for detecting fetal chromosomal aneuploidies were analyzed. The relationship between maternal age and common fetal chromosomal aneuploidy was observed.
RESULTS: The sensitivity, specificity, PPV, NPV of NIPS for detecting fetal trisomy 21 were 99.11, 99.96, 90.98, and 100%, respectively. These same parameters for detecting fetal trisomy 18 were 100, 99.94, 67.92, and 100%, respectively. Finally, these parameters for detecting trisomy 13 were 100, 99.96, 27.78, and 100%, respectively. The prevalence of fetal trisomy 21 increased exponentially with maternal age. The high-risk percentage incidence rate of fetal trisomy 21 was significantly higher in the pregnant women at 37 years old or above than that in pregnant women at 35 to 37 years old. (Youden index = 37).
CONCLUSION: It is indicated that NIPS is an effective prenatal screening method for pregnant women at AMA.

Entities:  

Keywords:  Advanced maternal age (AMA); Fetal chromosomal aneuploidies; Non-invasive prenatal screening (NIPS); Prenatal screening method; Trisomy

Mesh:

Substances:

Year:  2021        PMID: 33499806      PMCID: PMC7836475          DOI: 10.1186/s12884-021-03570-6

Source DB:  PubMed          Journal:  BMC Pregnancy Childbirth        ISSN: 1471-2393            Impact factor:   3.007


  31 in total

1.  Presence of fetal DNA in maternal plasma and serum.

Authors:  Y M Lo; N Corbetta; P F Chamberlain; V Rai; I L Sargent; C W Redman; J S Wainscoat
Journal:  Lancet       Date:  1997-08-16       Impact factor: 79.321

2.  Advanced maternal age--how old is too old?

Authors:  Linda J Heffner
Journal:  N Engl J Med       Date:  2004-11-04       Impact factor: 91.245

3.  The inconsistency of "optimal" cutpoints obtained using two criteria based on the receiver operating characteristic curve.

Authors:  Neil J Perkins; Enrique F Schisterman
Journal:  Am J Epidemiol       Date:  2006-01-12       Impact factor: 4.897

Review 4.  Non-invasive prenatal testing for fetal chromosomal abnormalities by low-coverage whole-genome sequencing of maternal plasma DNA: review of 1982 consecutive cases in a single center.

Authors:  T K Lau; S W Cheung; P S S Lo; A N Pursley; M K Chan; F Jiang; H Zhang; W Wang; L F J Jong; O K C Yuen; H Y C Chan; W S K Chan; K W Choy
Journal:  Ultrasound Obstet Gynecol       Date:  2014-02-10       Impact factor: 7.299

Review 5.  The accuracy of cell-free fetal DNA-based non-invasive prenatal testing in singleton pregnancies: a systematic review and bivariate meta-analysis.

Authors:  F L Mackie; K Hemming; S Allen; R K Morris; M D Kilby
Journal:  BJOG       Date:  2016-05-31       Impact factor: 6.531

6.  Non-invasive prenatal assessment of trisomy 21 by multiplexed maternal plasma DNA sequencing: large scale validity study.

Authors:  Rossa W K Chiu; Ranjit Akolekar; Yama W L Zheng; Tak Y Leung; Hao Sun; K C Allen Chan; Fiona M F Lun; Attie T J I Go; Elizabeth T Lau; William W K To; Wing C Leung; Rebecca Y K Tang; Sidney K C Au-Yeung; Helena Lam; Yu Y Kung; Xiuqing Zhang; John M G van Vugt; Ryoko Minekawa; Mary H Y Tang; Jun Wang; Cees B M Oudejans; Tze K Lau; Kypros H Nicolaides; Y M Dennis Lo
Journal:  BMJ       Date:  2011-01-11

7.  The impact of maternal plasma DNA fetal fraction on next generation sequencing tests for common fetal aneuploidies.

Authors:  Jacob A Canick; Glenn E Palomaki; Edward M Kloza; Geralyn M Lambert-Messerlian; James E Haddow
Journal:  Prenat Diagn       Date:  2013-05-31       Impact factor: 3.050

8.  Revisiting the fetal loss rate after second-trimester genetic amniocentesis: a single center's 16-year experience.

Authors:  Anthony O Odibo; Diane L Gray; Jeffrey M Dicke; David M Stamilio; George A Macones; James P Crane
Journal:  Obstet Gynecol       Date:  2008-03       Impact factor: 7.661

9.  Fetoplacental mosaicism: potential implications for false-positive and false-negative noninvasive prenatal screening results.

Authors:  Francesca R Grati; Francesca Malvestiti; Jose C P B Ferreira; Komal Bajaj; Elisa Gaetani; Cristina Agrati; Beatrice Grimi; Francesca Dulcetti; Anna M Ruggeri; Simona De Toffol; Federico Maggi; Ronald Wapner; Susan Gross; Giuseppe Simoni
Journal:  Genet Med       Date:  2014-02-13       Impact factor: 8.822

10.  Analysis of the Characteristics of Pregnancy and Delivery before and after Implementation of the Two-child Policy.

Authors:  Hong-Xia Zhang; Yang-Yu Zhao; Yong-Qing Wang
Journal:  Chin Med J (Engl)       Date:  2018-01-05       Impact factor: 2.628

View more
  3 in total

1.  A Critical Evaluation of Validation and Clinical Experience Studies in Non-Invasive Prenatal Testing for Trisomies 21, 18, and 13 and Monosomy X.

Authors:  Zachary Demko; Brittany Prigmore; Peter Benn
Journal:  J Clin Med       Date:  2022-08-15       Impact factor: 4.964

2.  Genome-Wide Copy Number Variant and High-Throughput Transcriptomics Analyses of Placental Tissues Underscore Persisting Child Susceptibility in At-Risk Pregnancies Cleared in Standard Genetic Testing.

Authors:  Darina Czamara; Cristiana Cruceanu; Marius Lahti-Pulkkinen; Linda Dieckmann; Maik Ködel; Susann Sauer; Monika Rex-Haffner; Sara Sammallahti; Eero Kajantie; Hannele Laivuori; Jari Lahti; Katri Räikkönen; Elisabeth B Binder
Journal:  Int J Mol Sci       Date:  2022-09-28       Impact factor: 6.208

3.  Study on the Clinical Value of Noninvasive Prenatal Testing in Screening the Chromosomal Abnormalities of the Fetus in the Elderly Pregnant Women.

Authors:  Zhiping Gu; Mengmeng Du; Tianhui Xu; Chunyan Jin
Journal:  Comput Math Methods Med       Date:  2022-09-28       Impact factor: 2.809

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.